Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Association between topiramate and zonisamide use during pregnancy and low birth weight.

Hernández-Díaz S, Mittendorf R, Smith CR, Hauser WA, Yerby M, Holmes LB; North American Antiepileptic Drug Pregnancy Registry.

Obstet Gynecol. 2014 Jan;123(1):21-8. doi: 10.1097/AOG.0000000000000018.

PMID:
24463659
2.

Comparative safety of antiepileptic drugs during pregnancy.

Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB; North American AED Pregnancy Registry; North American AED Pregnancy Registry.

Neurology. 2012 May 22;78(21):1692-9. doi: 10.1212/WNL.0b013e3182574f39. Epub 2012 May 2.

PMID:
22551726
3.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
4.

Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality?

Pryde PG, Mittendorf R.

J Perinat Med. 2011 Jul;39(4):375-8. doi: 10.1515/JPM.2011.036. Epub 2011 Apr 14. Review.

PMID:
21488809
5.

Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose.

Pryde PG, Mittendorf R.

Obstet Gynecol. 2009 Sep;114(3):669-73. doi: 10.1097/AOG.0b013e3181b43b0e. Review.

PMID:
19701048
6.

Magnesium sulfate for the prevention of cerebral palsy.

Mittendorf R, Pryde PG.

N Engl J Med. 2009 Jan 8;360(2):189-90; author reply 190. doi: 10.1056/NEJMc081995. No abstract available.

7.

Relationships between umbilical cord arterial blood pH levels at delivery and Bayley Psychomotor Development Index scores in early childhood.

Mittendorf R, Won SY, Gianopoulos JG, Pryde PG, Roizen N.

J Perinat Med. 2008;36(4):335-40. doi: 10.1515/JPM.2008.043.

PMID:
18598124
8.

Magnesium sulfate tocolysis: time to quit.

Mittendorf R.

Obstet Gynecol. 2007 May;109(5):1204-5. No abstract available.

PMID:
17470609
9.

Neuroprophylaxis with aminophylline and magnesium sulfate?

Mittendorf R, Pyrde PG.

Am J Obstet Gynecol. 2006 Feb;194(2):593; author reply 594. No abstract available.

PMID:
16458673
10.

Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.

Mittendorf R, Dammann O, Lee KS.

J Perinatol. 2006 Jan 1;26(1):57-63. Review.

PMID:
16319938
11.

Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates.

Mittendorf R, Covert R, Montag AG, elMasri W, Muraskas J, Lee KS, Pryde PG.

J Perinat Med. 2005;33(5):428-34.

PMID:
16238538
12.

A review of the role for magnesium sulphate in preterm labour.

Mittendorf R, Pryde PG.

BJOG. 2005 Mar;112 Suppl 1:84-8. Review.

13.

Risk-benefit effects of tocolytic therapy.

Pryde PG, Janeczek S, Mittendorf R.

Expert Opin Drug Saf. 2004 Nov;3(6):639-54. Review.

PMID:
15500422
14.

Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates.

Mittendorf R, Kuban K, Pryde PG, Gianopoulos JG, Yousefzadeh D.

J Perinatol. 2005 Feb;25(2):101-7.

PMID:
15496867
15.

Association between lenticulostriate vasculopathy (LSV) and neonatal intraventricular hemorrhage (IVH).

Mittendorf R, Covert R, Pryde PG, Lee KS, Ben-Ami T, Yousefzadeh D.

J Perinatol. 2004 Nov;24(11):700-5.

PMID:
15254561
16.

The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.

Mittendorf R, Roizen NJ, Pryde PG.

J Perinatol. 2004 Jul;24(7):465-6. No abstract available.

PMID:
15224123
17.

Second overview of relationships between antenatal pharmacologic magnesium sulfate and neurologic outcomes in children.

Mittendorf R, Pryde PG, Roizen N.

J Perinat Med. 2004;32(3):201-10. Review.

PMID:
15188791
18.

Identification of isolated lenticulostriate vasculopathy in preterm infants.

Mittendorf R, Pryde PG, Roizen N.

J Perinatol. 2004 Apr;24(4):271; author reply 272. No abstract available.

PMID:
15067304
19.

Magnesium sulfate for preterm neuroprotection.

Mittendorf R, Lee KS, Roizen NJ, Pryde PG.

JAMA. 2004 Feb 25;291(8):940-1; author reply 941. No abstract available.

PMID:
14982906
20.

Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.

Mittendorf R, Pryde PG, Lee KS.

Am J Obstet Gynecol. 2003 Aug;189(2):613. No abstract available.

PMID:
14524362
21.

Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children.

Mittendorf R, Montag AG, MacMillan W, Janeczek S, Pryde PG, Besinger RE, Gianopoulos JG, Roizen N.

Am J Obstet Gynecol. 2003 Jun;188(6):1438-4; discussion 1444-6.

PMID:
12824976
22.

Relationship between hypermagnesaemia in preterm labour and adverse health outcomes in babies.

Mittendorf R, Pryde PG, Elin RJ, Gianopoulos JG, Lee KS.

Magnes Res. 2002 Dec;15(3-4):253-61. Review.

PMID:
12635881
23.

The magpie trial.

Mittendorf R, Pryde PG, Herschel M, Lee KS.

Lancet. 2002 Oct 26;360(9342):1330-1; author reply 1331-2. No abstract available.

PMID:
12414229
24.

Association between maternal obesity and fetal cardiac malformations in African Americans.

Mikhail LN, Walker CK, Mittendorf R.

J Natl Med Assoc. 2002 Aug;94(8):695-700.

25.

Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.

Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, Tomich PG.

Am J Obstet Gynecol. 2002 Jun;186(6):1111-8.

PMID:
12066082
26.

Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage.

Mittendorf R, Dambrosia J, Dammann O, Pryde PG, Lee KS, Ben-Ami TE, Yousefzadeh D.

J Pediatr. 2002 May;140(5):540-6.

PMID:
12032519
27.

Is intrapartum vibroacoustic stimulation an effective predictor of fetal acidosis?

Lin CC, Vassallo B, Mittendorf R.

J Perinat Med. 2001;29(6):506-12.

PMID:
11776681
28.

Adverse and beneficial effects of tocolytic therapy.

Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R.

Semin Perinatol. 2001 Oct;25(5):316-40. Review.

PMID:
11707019
29.

Infant mortality from congenital malformations in the United States, 1970-1997.

Lee K, Khoshnood B, Chen L, Wall SN, Cromie WJ, Mittendorf RL.

Obstet Gynecol. 2001 Oct;98(4):620-7.

PMID:
11576578
30.

Tocolytic magnesium sulfate toxicity and unexpected neonatal death.

Herschel M, Mittendorf R.

J Perinatol. 2001 Jun;21(4):261-2.

31.

Umbilical cord serum ionized magnesium level and total pediatric mortality.

Mittendorf R, Covert R, Elin R, Pryde PG, Khoshnood B, Lee K.

Obstet Gynecol. 2001 Jul;98(1):75-8.

PMID:
11430960
32.

Presurgical plasma exchange for severe factor V deficiency.

Baron BW, Mittendorf R, Baron JM.

J Clin Apher. 2001;16(1):29-30.

PMID:
11309828
33.

The association of coagulase-negative staphylococci isolated from the chorioamnion at delivery and subsequent development of cerebral palsy.

Mittendorf R, Covert R, Kohn J, Roizen N, Khoshnood B, Lee KS.

J Perinatol. 2001 Jan-Feb;21(1):3-8.

PMID:
11268865
34.

Association between funisitis and elevated interleukin-6 in cord blood.

Naccasha N, Hinson R, Montag A, Ismail M, Bentz L, Mittendorf R.

Obstet Gynecol. 2001 Feb;97(2):220-4.

PMID:
11165585
35.

Age at any full-term pregnancy and breast cancer risk.

Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A, MacMahon B.

Am J Epidemiol. 2000 Apr 1;151(7):715-22.

PMID:
10752799
36.

Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

Khoshnood B, Pryde P, Wall S, Singh J, Mittendorf R, Lee KS.

Am J Public Health. 2000 Nov;90(11):1778-81.

37.

An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy.

Mittendorf R, Pryde PG.

J Perinat Med. 2000;28(4):286-93. Review.

PMID:
11031698
38.

Perinatal death and tocolytic magnesium sulfate.

Scudiero R, Khoshnood B, Pryde PG, Lee KS, Wall S, Mittendorf R.

Obstet Gynecol. 2000 Aug;96(2):178-82.

PMID:
10908759
39.

Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.

Shoff SM, Newcomb PA, Trentham-Dietz A, Remington PL, Mittendorf R, Greenberg ER, Willett WC.

Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):591-5.

40.

The control of labor.

Pryde PG, Mittendorf R.

N Engl J Med. 1999 Dec 30;341(27):2098-9. No abstract available.

41.

Association between cerebral palsy and coagulase-negative staphylococci.

Mittendorf R, Roizen N, Moawad A, Khoshnood B, Lee KS.

Lancet. 1999 Nov 27;354(9193):1875-6.

PMID:
10584728
42.

Length of pregnancy in African Americans: validation of a new predictive rule.

Mittendorf R, Chorzempa LM, Quinlan MP, Herschel M, Williams MA.

J Natl Med Assoc. 1999 Sep;91(9):523-7.

43.

Epidural analgesia and cesarean delivery.

Herschel M, Mittendorf R.

JAMA. 1999 Jun 9;281(22):2084-5; author reply 2086-7. No abstract available.

PMID:
10367811
44.

Is routine antenatal toxoplasmosis screening justified in the United States? Statistical considerations in the application of medical screening tests.

Mittendorf R, Pryde P, Herschel M, Williams MA.

Clin Obstet Gynecol. 1999 Mar;42(1):163-73; quiz 174-5. Review. No abstract available.

PMID:
10073309
45.

Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia.

Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA.

Am J Epidemiol. 1999 Feb 15;149(4):323-9.

PMID:
10025474
46.

Relationship of cesarean delivery to lower birth weight-specific neonatal mortality in singleton breech infants in the United States.

Lee KS, Khoshnood B, Sriram S, Hsieh HL, Singh J, Mittendorf R.

Obstet Gynecol. 1998 Nov;92(5):769-74.

PMID:
9794666
47.

Short interpregnancy intervals and the risk of adverse birth outcomes among five racial/ethnic groups in the United States.

Khoshnood B, Lee KS, Wall S, Hsieh HL, Mittendorf R.

Am J Epidemiol. 1998 Oct 15;148(8):798-805.

PMID:
9786235
48.

Menstrual factors in relation to breast cancer risk.

Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W.

Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):783-9.

49.

Cancer risk in women exposed to diethylstilbestrol in utero.

Hatch EE, Palmer JR, Titus-Ernstoff L, Noller KL, Kaufman RH, Mittendorf R, Robboy SJ, Hyer M, Cowan CM, Adam E, Colton T, Hartge P, Hoover RN.

JAMA. 1998 Aug 19;280(7):630-4.

PMID:
9718055
50.

Tocolytic magnesium sulfate: are the epidemiologic data reassuring?

Mittendorf R, Pryde P.

Am J Obstet Gynecol. 1998 Jul;179(1):280. No abstract available.

PMID:
9704810

Supplemental Content

Loading ...
Support Center